Skip to content

Clinical trials

Phase 2 Retinitis Pigmentosa trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinitis Pigmentosa Phase: Phase 2 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20072
20101
20112
20121
20141
20152
20162
20171
20191
20201
20214
20221
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status4
Active, not recruiting2
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Laboratoires Thea3
Neurotech Pharmaceuticals3
jCyte, Inc3
Aldeyra Therapeutics, Inc.1
Beirut Eye Specialist Hospital1
Columbia University1
Foundation Fighting Blindness1
Jinnah Burn and Reconstructive Surgery Centre, Lahore1
Kiora Pharmaceuticals, Inc.1
Moorfields Eye Hospital NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinitis Pigmentosa25
Retinal Diseases8
Eye Diseases5
Eye Diseases, Hereditary4
Usher Syndromes4
Macular Edema3
Vision Disorders3
Eye Abnormalities2
Retinal Degeneration2
Central Serous Chorioretinopathy1

Trials

Showing 76 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.